14 results
8-K
EX-99.1
RGEN
Repligen Corp.
21 Sep 12
Repligen Appoints Jonathan I. Lieber as CFO
12:00am
a particularly relevant skill set to the management team. His combined life sciences and capital markets expertise will be major assets to the Company
8-K
EX-99.2
RGEN
Repligen Corp.
28 Oct 11
Entry into a Material Definitive Agreement
12:00am
skill sets
Transaction Summary
Novozymes Biopharma AB Profile
Novozymes Biopharma AB is a manufacturing business with
two principal product lines
8-K
EX-99.1
RGEN
Repligen Corp.
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
such knowledge, skill and experience in business, financial and investment matters that the Investor and each Account is capable of evaluating the merits
S-3ASR
EX-4.4
2epq qsix2
29 Apr 19
Automatic shelf registration
4:15pm
8-K
EX-4.1
egjqcw1
22 Jul 19
Entry into a Material Definitive Agreement
5:09pm
S-3ASR
EX-4.3
ae5mqh
29 Apr 19
Automatic shelf registration
4:15pm
DEFR14A
k3uwp01yzgi09w8u8m
5 May 21
Revised proxy
4:16pm
8-K
EX-4.1
6pr5790
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
- Prev
- 1
- Next